English
English

Making everyone happy with data, everyday!

Making everyone happy with data, everyday!

Making everyone happy with data, everyday!

Gencovery purpose is to build the largest open and easy-to-access digital infrastructure, to make data more accessible to any scientists around the world in order to advance life sciences and speed-up innovation.

Gencovery purpose is to build the largest open and easy-to-access digital infrastructure, to make data more accessible to any scientists around the world in order to advance life sciences and speed-up innovation.

Gencovery purpose is to build the largest open and easy-to-access digital infrastructure, to make data more accessible to any scientists around the world in order to advance life sciences and speed-up innovation.

Our vision

We envision to be the global digital leader for a universal access to data and artificial intelligence in life sciences and our society.

Our mission

Our mission is to develop Constellab™, the open and full digital ecosystem to connect any data, artificial intelligence and scientists at every stage of the R&D value chain.

Our values

Sharing

We believe in collaboration for efficient and sustainable knowledge sharing. We promote open data to make knowledge accessible to everyone

Commitment and integrity

We are committed to building a world with ethical and responsible use of data and artificial intelligence

Pragmatism

We are user-centric, committed to democratize artificial intelligence and digital twins by making these technologies easy to use by people

Corporate Social Responsability

Education

Training of new young generations is at the heart of our values and priorities to make to democratization of AI

Environmental impact

Our technologies are designed to be green-computing compliant and reduce the carbon footprint of the digital

Open innovation

We are open-source for a universal access to data and reduce inequalities in new digital era

Employment growth

Gencovery put an importance to have huge economic and social impact by creating new employments and services

Our history and roadmap

A concept initiated by two founders

Gencovery is the realisation of an idea that has been maturing since 2013 following a simple observation: developing a drug takes more than 15 years. Out of more than 10,000 molecules tested, only 1 gives a drug. Most of data generated for the other 9,999 molecules remained untapped. If we take the analogy of the iceberg: we use less than 10% of knowledge on the surface of the water and the remaining 90% is a new world of knowledge to explore.


However, it is harder and harder for scientists to harness these data and innovate. Indeed, over 90% of scientists are biologists, not data specialists, and there is a urgent need of a easy-to-access digital infrastructure to make data more accessible and ramp up R&D.


Gencovery purpose is to build the largest open and easy-to-access digital infrastructure, to make data more accessible to any scientists around the world in order to advance life sciences and speed-up innovation.


Gencovery is the contraction of the words: GENE and DISCOVERY.


Since the beginning, Gencovery is supported by BIOASTER, LifeHub Lyon and SATT PULSALYS. 

01
01
01

2020 - Foundation

Gencovery is founded by 2 research scientists in applied mathematics, graduates of Ecole Centrale de Nantes (Adama OUATTARA, PhD) and Ecole polytechnique (Wassim ABOU-JAOUDE, PhD). Gencovery is supported by the Technology Research Institute BIOASTER. We are incubated by SATT PULSALYS and LifeHub Lyon (Bayer).

2020 - Foundation

Gencovery is founded by 2 research scientists in applied mathematics, graduates of Ecole Centrale de Nantes (Adama OUATTARA, PhD) and Ecole polytechnique (Wassim ABOU-JAOUDE, PhD). Gencovery is supported by the Technology Research Institute BIOASTER. We are incubated by SATT PULSALYS and LifeHub Lyon (Bayer).

2020 - Foundation

Gencovery is founded by 2 research scientists in applied mathematics, graduates of Ecole Centrale de Nantes (Adama OUATTARA, PhD) and Ecole polytechnique (Wassim ABOU-JAOUDE, PhD). Gencovery is supported by the Technology Research Institute BIOASTER. We are incubated by SATT PULSALYS and LifeHub Lyon (Bayer).

2021

  • Gencovery deployed a first prototype of its digital platform and secured an initial contract with BAYER in Lyon (France).


  • Constellab™ is used in research and development to enhance the knowledge of microorganisms biology by utilizing AI and digital twins to design safer and more effective crops protection products.

2021

  • Gencovery deployed a first prototype of its digital platform and secured an initial contract with BAYER in Lyon (France).


  • Constellab™ is used in research and development to enhance the knowledge of microorganisms biology by utilizing AI and digital twins to design safer and more effective crops protection products.

2021

  • Gencovery deployed a first prototype of its digital platform and secured an initial contract with BAYER in Lyon (France).


  • Constellab™ is used in research and development to enhance the knowledge of microorganisms biology by utilizing AI and digital twins to design safer and more effective crops protection products.

02
02
02
03
03
03

2022

  • Constellab™ is now available in the cloud of OVHcloud and is adopted by the biotech company Adisseo to develop new solutions to improve nutrition


  • Constellab™ Community platform is available to provide documentation on Constellab™ for better support of our clients.


  • Gencovery won the R&D Booster 2022 call. Gencovery, Greencell, and BIOASTER are partnering to develop second-generation digital twins to improve bioprocess reliability with AI

2022

  • Constellab™ is now available in the cloud of OVHcloud and is adopted by the biotech company Adisseo to develop new solutions to improve nutrition


  • Constellab™ Community platform is available to provide documentation on Constellab™ for better support of our clients.


  • Gencovery won the R&D Booster 2022 call. Gencovery, Greencell, and BIOASTER are partnering to develop second-generation digital twins to improve bioprocess reliability with AI

2022

  • Constellab™ is now available in the cloud of OVHcloud and is adopted by the biotech company Adisseo to develop new solutions to improve nutrition


  • Constellab™ Community platform is available to provide documentation on Constellab™ for better support of our clients.


  • Gencovery won the R&D Booster 2022 call. Gencovery, Greencell, and BIOASTER are partnering to develop second-generation digital twins to improve bioprocess reliability with AI

2023

  • Gencovery is launching Constellab™ version 1, which has received positive feedback from its users. The company has developed a strong customer-success process.

  • Constellab™ is now available in cloud of Microsoft AZURE and can be deployed on premises


  • Gencovery initiated strategic collaborations with

    • the engineering school SupBiotech to support the training of AI and bioinformatics

    • Institut Imagine (AP-HP, hospitals of Paris) to apply digital twins to understand the metabolic mechanisms of rare genetic diseases


  • Constellab™ now provides generative AI to speed-up data exploration and visualization

  • Gencovery is accelerating its go-to-market by deploying a strong and mature marketing and sales force

2023

  • Gencovery is launching Constellab™ version 1, which has received positive feedback from its users. The company has developed a strong customer-success process.

  • Constellab™ is now available in cloud of Microsoft AZURE and can be deployed on premises


  • Gencovery initiated strategic collaborations with

    • the engineering school SupBiotech to support the training of AI and bioinformatics

    • Institut Imagine (AP-HP, hospitals of Paris) to apply digital twins to understand the metabolic mechanisms of rare genetic diseases


  • Constellab™ now provides generative AI to speed-up data exploration and visualization

  • Gencovery is accelerating its go-to-market by deploying a strong and mature marketing and sales force

2023

  • Gencovery is launching Constellab™ version 1, which has received positive feedback from its users. The company has developed a strong customer-success process.

  • Constellab™ is now available in cloud of Microsoft AZURE and can be deployed on premises


  • Gencovery initiated strategic collaborations with

    • the engineering school SupBiotech to support the training of AI and bioinformatics

    • Institut Imagine (AP-HP, hospitals of Paris) to apply digital twins to understand the metabolic mechanisms of rare genetic diseases


  • Constellab™ now provides generative AI to speed-up data exploration and visualization

  • Gencovery is accelerating its go-to-market by deploying a strong and mature marketing and sales force

04
04
04
05
05
05

2024 -

  • Release the first R&D Assistant in Constellab™

  • Expansion to the international by 2024 - Q3

  • Reach of the breakeven point by 2025

  • Deployment of Constellab™ for biotech 4.0 by 2025

2024 -

  • Release the first R&D Assistant in Constellab™

  • Expansion to the international by 2024 - Q3

  • Reach of the breakeven point by 2025

  • Deployment of Constellab™ for biotech 4.0 by 2025

2024 -

  • Release the first R&D Assistant in Constellab™

  • Expansion to the international by 2024 - Q3

  • Reach of the breakeven point by 2025

  • Deployment of Constellab™ for biotech 4.0 by 2025